ANALYSIS OF RELAPSE RATE AND METASTASES OF HIGH DIFFERENTIATED THYROID CANCER
https://doi.org/10.17650/2222-1468-2015-1-19-21
Abstract
Analysis of rate of relapses and metastases with well-differentiated thyroid cancer was performed for patients in 2009 to 2013. The study involved 189 patients with thyroid cancer including 98 (51.9 %) patients suffering from papillary thyroid cancer, 77 (40.7 %) patients suffering from follicular thyroid cancer, and 14 (7.4 %) patients suffering from medullary thyroid cancer. 2.04 % of the 98 patients suffering from papillary thyroid cancer manifested a relapse, and lymphogenic metastases of cancer were revealed with 1.0 % of patients. With follicular thyroid cancer (n = 77), lymphogenic metastases were registered in 7.8 % of cases, relapses were revealed in 1.3 % of cases. This analysis demonstrated that observation of patients for 5 years revealed a higher percentage of metastases with patients that suffered from follicular thyroid cancer.
About the Authors
E. V. SavenokRussian Federation
E. S. Minakova
Russian Federation
O. V. Ryzhikh
Russian Federation
VoronezhRegional Clinical Oncological Dispensary;4 Vaitsekhovskogo St.,Voronezh, 394036,Russia;
Department of Oncology, Radiation Therapy, and Radiation Diagnostics of N.N.BurdenkoVoronezhStateMedicalAcademy, Ministry of Health ofRussia;10 Studencheskaya St.,Voronezh, 394036,Russia
E. D. Panov
Russian Federation
E. A. Karapetyan
Russian Federation
References
1. Барчук А.С. Рецидивы дифференцированного рака щитовидной железы. Практическая онкология 2007;8(1):35–41. [Barchuk A.S. Relapses of differentiated thyroid cancer. Prakticheskaya onkologiya = Practical Oncology 2007;8(1):35–41 (In Russ.)].
2. Пинский С.Б., Дворниченко В.В., Белобородов В.А. Опухоли щитовидной железы. Иркутск, 1999. [Pinskiy S.B., Dvornichenko V.V., Beloborodov V.A. Thyroid gland tumors. Irkutsk, 1999 (In Russ.)].
3. Hegedus L., Bonnema S.J., Bennedbaek F.N. Management of simple nodular goiter: current status and future perspectives. Endocr Rev 2003;24(1):102–32.
4. Новожилова Е.Н. Показания к повторным операциям при раке щитовидной железы. Онкология на рубеже веков. М., 1999. С. 270–271. [Novozhilova E.N. Indications for repeated surgical operations with thyroid cancer. Oncology at the turn of the century. Moscow, 1999. Pp. 270–271 (In Russ.)].
5. Чиссов В.И., Ольшанский В.О., Трофимова Е.Ю., Новожилова Е.Н. Показания к повторным операциям при раке щитовидной железы. Российский онкологический журнал 1998;1:27–9. [Chissov V.I., Olshanskiy V.O., Trofimova E.Yu., Novozhilova E.N. Indications for repeated surgical operations with thyroid cancer. Rossiyskiy Onkologicheskiy Zhurnal = Russian Journal of Oncology 1998;1:27–9 (In Russ.)].
6. Яйцев С.В. Клинико-эпидемиологическая характеристика, пути профилактики и прогнозирования рака щитовидной железы. Автореф. дис. … д-ра мед. наук. Челябинск, 2000. С. 43. [Yaitsev S.V. Clinical and epidemiological characteristics, methods of prevention and prognosis of thyroid cancer. Author's abstract ... of MD thesis. Chelyabinsk, 2000. P. 43 (In Russ.)].
7. Duren M., Siperstein A.E., Shen W. et al. Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in highand low-risk patients. Surgery 1999;126(1): 13–9.
Review
For citations:
Savenok E.V., Minakova E.S., Ryzhikh O.V., Panov E.D., Karapetyan E.A. ANALYSIS OF RELAPSE RATE AND METASTASES OF HIGH DIFFERENTIATED THYROID CANCER. Head and Neck Tumors (HNT). 2015;5(1):19-21. (In Russ.) https://doi.org/10.17650/2222-1468-2015-1-19-21